Satish Waman Wagh files SEBI Regulation 31(4) takeover disclosure for Supriya Lifescience

M&A / JV 29 Jun 2026 · Announced· ✓ Verified

Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 requires disclosure within 4 trading days of crossing prescribed thresholds (typically 5%, 10%, 15%, 20%, 25% and 50% of voting capital). The filing by Satish Waman Wagh for Supriya Lifescience was submitted to NSE on or around 29 June 2026. The specific stake percentage, acquisition price, and deal consideration are not disclosed in the archival filing header available, but the Regulation 31(4) framework suggests a material shareholding event triggering regulatory oversight.

Why it mattersThe filing triggers mandatory public disclosure obligations and may indicate a threshold breach (likely 25% or higher) requiring open offer or competing bid considerations under SEBI's takeover regime.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals